Unknown

Dataset Information

0

Ginsenoside-Rb1 targets chemotherapy-resistant ovarian cancer stem cells via simultaneous inhibition of Wnt/?-catenin signaling and epithelial-to-mesenchymal transition.


ABSTRACT: Chemoresistance is a major clinical problem compromising the successful treatment of cancer. One exciting approach is the eradication of cancer stem/tumor-initiating cells (jointly CSCs), which account for tumor initiation, progression, and drug resistance. Here we show for the first time, with mechanism-based evidence, that ginsenoside-Rb1, a natural saponin isolated from the rhizome of Panax quinquefolius and notoginseng, exhibits potent cytotoxicity on CSCs. Rb1 and its metabolite compound K could effectively suppress CSC self-renewal without regrowth. Rb1 and compound K treatment also sensitized the CSCs to clinically relevant doses of cisplatin and paclitaxel. These effects were associated with the Wnt/?-catenin signaling pathway by downregulating ?-catenin/T-cell factor-dependent transcription and expression of its target genes ATP-binding cassette G2 and P-glycoprotein. We also identified reversal of epithelial-to-mesenchymal transition as a new player in the Rb1 and compound K-mediated inhibition of CSCs. Rb1 and compound K treatment also inhibited the self-renewal of CSCs derived from ovarian carcinoma patients as well as in xenograft tumor model. Moreover, we did not observe toxicity in response to doses of Rb1 and compound K that produced an anti-CSC effect. Therefore, Rb1 should be explored further as a promising nutraceutical prototype of treating refractory tumors.

SUBMITTER: Deng S 

PROVIDER: S-EPMC5432225 | biostudies-literature | 2017 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

Ginsenoside-Rb1 targets chemotherapy-resistant ovarian cancer stem cells via simultaneous inhibition of Wnt/β-catenin signaling and epithelial-to-mesenchymal transition.

Deng Shan S   Wong Chris Kong Chu CKC   Lai Hung-Cheng HC   Wong Alice Sze Tsai AST  

Oncotarget 20170401 16


Chemoresistance is a major clinical problem compromising the successful treatment of cancer. One exciting approach is the eradication of cancer stem/tumor-initiating cells (jointly CSCs), which account for tumor initiation, progression, and drug resistance. Here we show for the first time, with mechanism-based evidence, that ginsenoside-Rb1, a natural saponin isolated from the rhizome of Panax quinquefolius and notoginseng, exhibits potent cytotoxicity on CSCs. Rb1 and its metabolite compound K  ...[more]

Similar Datasets

| S-EPMC6787443 | biostudies-literature
| S-EPMC4157750 | biostudies-literature
| S-EPMC5642532 | biostudies-literature
| S-EPMC5024152 | biostudies-literature
| S-EPMC8571878 | biostudies-literature
| S-EPMC9401105 | biostudies-literature
| S-EPMC7052920 | biostudies-literature
| S-EPMC7448411 | biostudies-literature
| S-EPMC8210560 | biostudies-literature
| S-EPMC6525164 | biostudies-literature